SPACInsider•4 days ago
Panbela Therapeutics, Inc. is a biopharmaceutical company developing disruptive treatments for patients with cancer. It focuses on pancreatic cancer, colorectal cancer, and ovarian cancer. The company's lead product candidate, SBP-101, is in Phase Ia/Ib clinical trial for the treatment of metastatic pancreatic ductal adenocarcinoma. Panbela Therapeutics was incorporated in 2011 and is headquartered in Waconia, MN.
What is Panbela Therapeutics's quote symbol?
What is the 52 week high and low for Panbela Therapeutics (NASDAQ: PBLA)?
How much is Panbela Therapeutics stock worth today?
How much is Panbela Therapeutics's stock price per share?
What is Panbela Therapeutics's Market Cap?